Trials / Conditions / Lymphoma, Non-hodgkins
Lymphoma, Non-hodgkins
6 registered clinical trials studyying Lymphoma, Non-hodgkins — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) NCT06343311 | Estrella Biopharma, Inc. | Phase 1 / Phase 2 |
| Terminated | T Cells Expressing Fully-human Anti-CD19 and Anti-CD20 Chimeric Antigen Receptors for Treating B-cell Malignan NCT04160195 | National Cancer Institute (NCI) | Phase 1 |
| Completed | T Cells Expressing a Fully-human AntiCD19 Chimeric Antigen Receptor for Treating B-cell Malignancies NCT02659943 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to NCT01087294 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Ofatumumab and Bortezomib for Patients With Low-grade B-cell Non-hodgkin Lymphoma That Relapse After Rituximab NCT01119794 | Brown University | Phase 2 |
| Completed | Health and Psychosocial Outcomes in Long-Term Lymphoma Survivors NCT00713882 | Weill Medical College of Cornell University | — |